PCG
SUPN icon

Private Capital Group’s Supernus Pharmaceuticals SUPN Stock Holding History

Private Capital Group’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$8K Sell
263
-18
-6% -$516 0.01% 1125
2022
Q1 		$9K Buy
281
+53
+23% +$1.63K ﹤0.01% 1318
2021
Q4 		$7K Buy
228
+6
+3% +$182 ﹤0.01% 1448
2021
Q3 		$6K Sell
222
-48
-18% -$1.29K ﹤0.01% 1529
2021
Q2 		$8K Sell
270
-47
-15% -$1.44K ﹤0.01% 1424
2021
Q1 		$8K Buy
317
+145
+84% +$4.05K ﹤0.01% 1375
2020
Q4 		$4K Sell
172
-73
-30% -$1.57K ﹤0.01% 1623
2020
Q3 		$5K Buy
245
+62
+34% +$1.41K ﹤0.01% 1521
2020
Q2 		$4K Sell
183
-61
-25% -$1.35K ﹤0.01% 1572
2020
Q1 		$4K Sell
244
-118
-33% -$2.48K ﹤0.01% 1557
2019
Q4 		$8K Buy
362
+11
+3% +$267 ﹤0.01% 1406
2019
Q3 		$10K Sell
351
-1,028
-75% -$30.5K ﹤0.01% 1478
2019
Q2 		$83K Buy
1,379
+716
+108% +$24.5K 0.02% 464
2019
Q1 		$23K Sell
663
-215
-24% -$8K ﹤0.01% 1128
2018
Q4 		$29K Sell
878
-170
-16% -$7.31K 0.01% 927
2018
Q3 		$52K Sell
1,048
-331
-24% -$16.3K 0.01% 700
2018
Q2 		$82K Buy
1,379
+215
+18% +$11.1K 0.02% 495
2018
Q1 		$53K Buy
1,164
+36
+3% +$1.5K 0.01% 649
2017
Q4 		$45K Buy
+1,128
New +$44.6K 0.01% 739

Other funds holding SUPN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Private Capital Group's SUPN Position: Q2 2022 in Review

Private Capital Group reduced its Supernus Pharmaceuticals (SUPN) stake by 6.4% in Q2 2022, selling an estimated $516 and leaving 263 shares worth $8K. The position accounts for 0.01% of the portfolio, ranked #1125.

Private Capital Group first reported a position in SUPN in Q4 2017 and has held it in 19 quarters since. The position peaked at $83K in Q2 2019. 225 funds tracked by Wall St. Rank hold SUPN as of Q2 2022.

  • Private Capital Group held 263 shares of Supernus Pharmaceuticals worth $8K as of Q2 2022.
  • Private Capital Group sold 18 Supernus Pharmaceuticals shares in Q2 2022, an estimated $516.
  • Supernus Pharmaceuticals made up 0.01% of Private Capital Group's portfolio in Q2 2022, its #1125 holding.
  • Private Capital Group first reported a position in Supernus Pharmaceuticals in Q4 2017 and has held it in 19 quarters since.
  • Private Capital Group's Supernus Pharmaceuticals position peaked at $83K in Q2 2019.
  • 225 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2022.

Based on Private Capital Group's 13F filing for Q2 2022, filed 28 Jul 2022.